Home
Conditions
Lymphoma, B-Cell

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

1,618 public trials 340 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Completed

Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas

NCT00101270

Conditions: Astrocytoma, Burkitt Lymphoma, Childhood Burkitt Lymphoma, +115 more
Locations: COG Phase I Consortium Arcadia, California, United States

View Trial Details

Completed

Pyroxamide in Treating Patients With Advanced Cancer

NCT00042900

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +90 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma

NCT00058227

Conditions: B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +71 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease

NCT00005613

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
Locations: Florida Cancer Specialists Fort Myers, Florida, United States

H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma

NCT00006373

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Decitabine With or Without Valproic Acid in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00109824

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +19 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid Leukemia

NCT00017472

Conditions: Chronic Disease, Disease Attributes, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, +34 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma

NCT00659568

Conditions: Adenocarcinoma, Blood Protein Disorders, Breast Cancer, +84 more
Locations: London Regional Cancer Program at London Health Sciences Centre London, Ontario, Canada

View Trial Details

Completed

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer

NCT00045006

Conditions: Adenocarcinoma, Adnexal Diseases, Blood Protein Disorders, +110 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma

NCT00059995

Conditions: Dendritic Cell Sarcoma, Interdigitating, Disease Attributes, Hemic and Lymphatic Diseases, +19 more
Locations: Mayo Clinic Cancer Center Rochester, Minnesota, United States

Memorial Sloan-Kettering Cancer Center New York, United States

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Columbus, Ohio, United States

View Trial Details

Lymphoma, B-Cell

Lymphoma, B-Cell trial results

Related conditions